41 Stocks Moving In Friday’s Mid-Day Session
Gainers
IO Biotech, Inc. (NASDAQ: IOBT) jumped 42% to $11.74. The company, last month, priced its IPO at $14 per share.
Mid-Morning Market Update: Markets Open Lower; Big Lots Issues Weak Profit Forecast
Following the market opening Friday, the Dow traded down 0.31% to 34,532.63 while the NASDAQ fell 1.44% to 15,160.41. The S&P also fell, dropping 0.60% to 4,549.65.
Morgan Stanley Initiates Coverage On IO Biotech with Overweight Rating, Announces Price Target of $21
Morgan Stanley analyst Matthew Harrison initiates coverage on IO Biotech (NASDAQ:IOBT) with a Overweight rating and announces Price Target of $21.
Cowen & Co. Initiates Coverage On IO Biotech with Outperform Rating
Cowen & Co. analyst Yaron Werber initiates coverage on IO Biotech (NASDAQ:IOBT) with a Outperform rating.
Jefferies Initiates Coverage On IO Biotech with Buy Rating, Announces Price Target of $20
Jefferies analyst Chris Howerton initiates coverage on IO Biotech (NASDAQ:IOBT) with a Buy rating and announces Price Target of $20.
The Week Ahead In Biotech (Nov. 28-Dec. 4): FDA Decisions For VBI Vaccines, BeyondSpring, CTI Biopharma And Merck Take The Spotlight In A Light Calendar Week
Biotech stocks advanced in the week ending Nov. 26, as a late-week surge on the back of news about a new COVID-19 variant, named Omicron, helped mitigate the losses notched earlier in the holiday-shortened week.
64 Biggest Movers From Yesterday
Gainers
Pioneer Power Solutions, Inc. (NASDAQ: PPSI) shares jumped 219% to close at $10.40 on Monday after the company announced the launch of its E-Boost portfolio of mobile Electric Vehicle charging solutions for a full range of applications.
The Daily Biotech Pulse: NRx’s Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill
Here's a roundup of top developments in the biotech space over the last 24 hours.